Literature DB >> 11503775

Occupational exposure to bloodborne pathogens; needlestick and other sharps injuries; final rule. Occupational Safety and Health Administration (OSHA), Department of Labor. Final rule; request for comment on the Information Collection (Paperwork) Requirements.

.   

Abstract

The Occupational Safety and Health Administration is revising the Bloodborne Pathogens standard in conformance with the requirements of the Needlestick Safety and Prevention Act. This Act directs OSHA to revise the Bloodborne Pathogens standard to include new examples in the definition of engineering controls along with two new definitions; to require that Exposure Control Plans reflect how employers implement new developments in control technology; to require employers to solicit input from employees responsible for direct patient care in the identification, evaluation, and selection of engineering and work practice controls; and to require certain employers to establish and maintain a log of percutaneous injuries from contaminated sharps.

Entities:  

Mesh:

Year:  2001        PMID: 11503775

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  13 in total

Review 1.  Endoscopic complications--avoidance and management.

Authors:  Daniel Blero; Jacques Devière
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-14       Impact factor: 46.802

2.  Intelliject's novel epinephrine autoinjector: sharps injury prevention validation and comparable analysis with EpiPen and Twinject.

Authors:  Stephanie Guerlain; Lu Wang; Akilah Hugine
Journal:  Ann Allergy Asthma Immunol       Date:  2010-12       Impact factor: 6.347

3.  National Evaluation of Needlestick Events and Reporting Among Surgical Residents.

Authors:  Anthony D Yang; Christopher M Quinn; D Brock Hewitt; Jeanette W Chung; Teresa R Zembower; Andrew Jones; Jo Buyske; David B Hoyt; Thomas J Nasca; Karl Y Bilimoria
Journal:  J Am Coll Surg       Date:  2019-09-18       Impact factor: 6.113

4.  SHEA/APIC guideline: infection prevention and control in the long-term care facility, July 2008.

Authors:  Philip W Smith; Gail Bennett; Suzanne Bradley; Paul Drinka; Ebbing Lautenbach; James Marx; Lona Mody; Lindsay Nicolle; Kurt Stevenson
Journal:  Infect Control Hosp Epidemiol       Date:  2008-09       Impact factor: 3.254

5.  Hepatitis B virus transmissions associated with a portable dental clinic, West Virginia, 2009.

Authors:  Rachel A Radcliffe; Danae Bixler; Anne Moorman; Vicki A Hogan; Vickie S Greenfield; Diana M Gaviria; Priti R Patel; Melissa K Schaefer; Amy S Collins; Yury E Khudyakov; Jan Drobeniuc; Barbara F Gooch; Jennifer L Cleveland
Journal:  J Am Dent Assoc       Date:  2013       Impact factor: 3.634

6.  Characterisation of occupational blood and body fluid exposures beyond the Needlestick Safety and Prevention Act.

Authors:  Judith Green-McKenzie; Ronda B McCarthy; Frances S Shofer
Journal:  J Infect Prev       Date:  2016-04-27

7.  Occupational safety among dental health-care workers.

Authors:  Shigehiro Shimoji; Kohji Ishihama; Hidefumi Yamada; Masaki Okayama; Kouichi Yasuda; Tohru Shibutani; Tadashi Ogasawara; Hiroo Miyazawa; Kiyofumi Furusawa
Journal:  Adv Med Educ Pract       Date:  2010-10-11

8.  Prehospital medication administration: a randomised study comparing intranasal and intravenous routes.

Authors:  Cian McDermott; Niamh C Collins
Journal:  Emerg Med Int       Date:  2012-08-16       Impact factor: 1.112

Review 9.  SHEA/APIC Guideline: Infection prevention and control in the long-term care facility.

Authors:  Philip W Smith; Gail Bennett; Suzanne Bradley; Paul Drinka; Ebbing Lautenbach; James Marx; Lona Mody; Lindsay Nicolle; Kurt Stevenson
Journal:  Am J Infect Control       Date:  2008-09       Impact factor: 2.918

Review 10.  Use of safety-engineered devices by healthcare workers for intravenous and/or phlebotomy procedures in healthcare settings: a systematic review and meta-analysis.

Authors:  Rami A Ballout; Batoul Diab; Alain C Harb; Rami Tarabay; Selma Khamassi; Elie A Akl
Journal:  BMC Health Serv Res       Date:  2016-09-01       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.